Patent · US Active

Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate

US9278072B2 · kind B2 · utility

0Cited by

6References

16Claims

0Family size

Assignee

RICHTER GEDEON NYRT. · HU

Inventors

Janine Klose · Harsewinkel, DE
Johannes BARTHOLOMÄUS · Aachen, DE
Klaus-Michael Wilsmann
Georg Schramm · Stolberg, DE

Key dates

Filing date	Dec 10, 2004
Grant date	Mar 8, 2016
Priority date	—
Expiry date	Jun 28, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a hormonal contraceptive including 21 to 25 hormone-containing daily units, which contain a combination of ethinyloestradiol in an amount of ≧25 μg and chlormadinone acetate in an amount of ≧5 mg, and optionally 7 to 3 hormone-free daily units for oral administration to women.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.